4/4
08:14 am
kala
KALA BIO, Inc. (NASDAQ: KALA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $15.00 price target on the stock.
Medium
Report
KALA BIO, Inc. (NASDAQ: KALA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $15.00 price target on the stock.
3/31
08:00 am
kala
KALA BIO Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
Medium
Report
KALA BIO Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
2/26
08:00 am
kala
KALA BIO to Present at TD Cowen 45th Annual Health Care Conference
Low
Report
KALA BIO to Present at TD Cowen 45th Annual Health Care Conference
2/13
08:10 am
kala
KALA BIO, Inc. (NASDAQ: KALA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $15.00 price target on the stock.
Medium
Report
KALA BIO, Inc. (NASDAQ: KALA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $15.00 price target on the stock.
2/12
08:00 am
kala
KALA BIO Announces Chief Executive Officer Transition
High
Report
KALA BIO Announces Chief Executive Officer Transition